BPH Global (ASX:BP8) Days Payable : 0.00 (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is BPH Global Days Payable?

BPH Global's average Accounts Payable for the six months ended in Dec. 2023 was A$1.20 Mil. BPH Global's Cost of Goods Sold for the six months ended in Dec. 2023 was A$0.00 Mil.

The historical rank and industry rank for BPH Global's Days Payable or its related term are showing as below:

During the past 13 years, BPH Global's highest Days Payable was 870.38. The lowest was 0.45. And the median was 12.75.

ASX:BP8's Days Payable is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 89.29
* Ranked among companies with meaningful Days Payable only.

BPH Global's Days Payable stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).

BPH Global Days Payable Historical Data

The historical data trend for BPH Global's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BPH Global Days Payable Chart

BPH Global Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Payable

Get a 7-Day Free Trial

12.75

28.03

0.45

5.69

BPH Global Semi-Annual Data
	Dec07	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															18.07	38.54	-	-	-

Competitive Comparison of BPH Global's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, BPH Global's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BPH Global's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BPH Global's Days Payable distribution charts can be found below:

* The bar in red indicates where BPH Global's Days Payable falls into.

BPH Global Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

BPH Global's Days Payable for the fiscal year that ended in Jun. 2023 is calculated as

	Days Payable (A: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2022 )	+	Accounts Payable (A: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2023 )	*	Days in Period
=	( (0.368	+	1.282)	/	2 )	/	0	*	365
=	0.825					/	0	*	365
=	N/A

BPH Global's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (1.282	+	1.114)	/	2 )	/	0	*	365 / 2
=	1.198					/	0	*	365 / 2
=	N/A

BPH Global Days Payable Related Terms

Thank you for viewing the detailed overview of BPH Global's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

BPH Global (ASX:BP8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BPH Global Ltd (ASX:BP8) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

96 Elizabeth Street, Block Arcade, Office 324, Level 3, Melbourne, VIC, AUS, 3000

Website

https://www.scu.com.sg

BPH Global Ltd, formerly Stemcell United Ltd is a marine and agricultural biotechnology industry. Its only operating segment is sourcing, producing, marketing, and selling traditional medicines. The company's geographical segment includes Australia; Singapore; Malaysia and Greater China. The company's product comprises Cannabis sativa; Dendrobium Officinale and Daemonorops Draco Blume.

BPH Global (ASX:BP8) Headlines

No Headlines